• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Fierce London event panel
Biotech

Big Pharmas tell Fierce's London event about their ideal biotech

Dealmakers for five of the biggest pharmas shared the stage at Fierce's event in London to debate what they look for in a dream biotech partner.
Ben Adams Nov 18, 2026 5:18am
Fierce panel London

Fierce’s London event told it could be ‘Europe’s year to shine’

Nov 17, 2026 10:00am
Biogen

Biogen’s tau drug drives bigger benefits in Alzheimer’s update

Nov 18, 2026 9:26am
Clene Nanomedicine uses CRO Veristats biostatistics platform for FDA submission

Clene uses Veristat’s biostatistics platform for FDA submission

Nov 18, 2026 9:00am
Pfizer

Pfizer buys 3 in vivo CAR-Ts in $2.6B deal with China’s Starna

Nov 18, 2026 8:30am
Vertex

Vertex re-ups Genomics deal in long-running discovery pact

Nov 18, 2026 5:01am
More News

Priavoid’s Alzheimer’s pill fails to prove efficacy in ph. 2

Nov 18, 2026 4:21am

Merck axes $2.7B BTK inhibitor program after seeing ph. 3 data

Nov 18, 2026 3:11am
Fierce Pharma

Overton’s FDA nomination pulled by White House

Nov 17, 2026 9:15pm
Fierce Pharma

FDA slams China-heavy data in Summit’s ivonescimab CRL

Nov 17, 2026 4:48pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings